Drug release mechanisms of cast lipid implants

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 78, Issue 3, 2011, Pages 394-400

  Kreye, F ^a,b   Siepmann, F ^a,b   Willart, J F ^a   Descamps, M ^a   Siepmann, J ^a,b  

^a UNIV LILLE   (France)

^b France   (France)

Author keywords

Controlled release; Implant; Lipid; Melting; Release mechanism

Indexed keywords

LIPID; WATER;

ARTICLE; COMPRESSION; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG RELEASE; DRUG SOLUBILITY; EXPERIMENTAL STUDY; FLOW KINETICS; IMPLANT; MATHEMATICS; MELTING POINT; PHYSICAL CHEMISTRY; POWDER; PREDICTION; QUANTITATIVE ANALYSIS; TIME;

BRONCHODILATOR AGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG IMPLANTS; HOT TEMPERATURE; LIPIDS; MECHANICAL PROCESSES; MODELS, CHEMICAL; MODELS, THEORETICAL; PHARMACOKINETICS; PHYSICOCHEMICAL PROCESSES; POWDERS; SOLUBILITY; THEOPHYLLINE; WATER;

EID: 79960579858     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.02.011     Document Type: Article

References (34)

1. S. Mohl, and G. Winter Continuous release of rh-interferon α-2a from triglyceride matrices J. Control. Release 97 2004 67 78 (Pubitemid 38624510)
2. C. Guse, S. Koennings, F. Kreye, F. Siepmann, A. Goepferich, and J. Siepmann Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms Int. J. Pharm. 314 2006 137 144
3. S. Koennings, E. Garcion, N. Faisant, P. Menei, J.P. Benoit, and A. Goepferich In vitro investigation of lipid implants as a controlled release system for interleukin-18 Int. J. Pharm. 314 2006 145 152
4. S. Herrmann, G. Winter, S. Mohl, F. Siepmann, and J. Siepmann Mechanisms controlling protein release from lipidic implants: effects of PEG addition J. Control. Release 118 2007 161 168 (Pubitemid 46343669)
5. F. Kreye, F. Siepmann, and J. Siepmann Lipid implants as drug delivery systems Expert. Opin. Drug Deliv. 5 2008 291 307 (Pubitemid 351454379)
6. J. Myschik, W.T. McBurney, T. Rades, and S. Hook Immunostimulatory lipid implants containing Quil-A and DC-cholesterol Int. J. Pharm. 363 2008 91 98
7. S. Schulze, and G. Winter Lipid extrudates as novel sustained release systems for pharmaceutical proteins J. Control. Release 134 2009 177 185
8. M. Schwab, G. Sax, S. Schulze, and G. Winter Studies on the lipase induced degradation of lipid based drug delivery systems J. Control. Release 140 2009 27 33
9. F. Kreye, F. Siepmann, and J. Siepmann Drug release mechanisms of compressed lipid implants Int. J. Pharm. 404 2011 27 35
10. S. Allababidi, and J.C. Shah Efficacy and pharmacokinetics of site-specific cefazolin delivery using biodegradable implants in the prevention of post-operative wound infections Pharm. Res. 15 1998 325 333 (Pubitemid 28144248)
11. P. Wang, Implant preparations containing bioactive macromolecule for sustained delivery, US Patent 5939,380, 1999.
12. Y. Yamagata, K. Iga, and Y. Ogawa Novel sustained-release dosage forms of proteins using polyglycerol esters of fatty acids J. Control. Release 63 2000 319 329
13. D. Chilukuri, and J.C. Shah Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections Pharm. Res. 22 2005 563 572 (Pubitemid 40603254)
14. C. Guse, S. Koennings, A. Maschke, M. Hacker, C. Becker, S. Schreiner, T. Blunk, T. Spruss, and A. Goepferich Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids Int. J. Pharm. 314 2006 153 160
15. S. Koennings, A. Sapin, T. Blunk, P. Menei, and A. Goepferich Towards controlled release of BDNF - manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain J. Control. Release 119 2007 163 172 (Pubitemid 46754504)
16. A. Brunner, K. Maeder, and A. Goepferich PH and osmotic pressure inside biodegradable microspheres during erosion Pharm. Res. 16 1999 847 853 (Pubitemid 29284195)
17. T. Estey, J. Kang, S.P. Schwendeman, and J.F. Carpenter BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems J. Pharm. Sci. 95 2006 1626 1639 (Pubitemid 44049129)
18. P.Y. Wang Lipids as excipient in sustained release insulin implants Int. J. Pharm. 54 1989 223 230
19. S. Herrmann, S. Mohl, F. Siepmann, J. Siepmann, and G. Winter New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants Pharm. Res. 24 2007 1527 1537 (Pubitemid 46988219)
20. Y.E. Zhang, and J.B. Schwartz Melt granulaton and heat treatment for wax matrix-controlled drug release Drug Dev. Ind. Pharm. 29 2003 131 138 (Pubitemid 36292936)
21. T. Pongjanyakul, N.J. Medlicott, and I.G. Tucker Melted glyceryl palmitostearate (GPS) pellets for protein delivery Int. J. Pharm. 271 2004 53 62 (Pubitemid 38210084)
22. V. Knepp, A. Muchnik, S. Oldmark, and L. Kalashnikova Stability of nonaqueous suspension formulations of plasma derived factor IX and recombinant human alpha interferon at elevated temperatures Pharm. Res. 15 1998 1090 1095 (Pubitemid 28356928)
23. A.M. Klibanov Improving enzymes by using them in organic solvents Nature 409 2001 241 246 (Pubitemid 32144293)
24. D. Chapman The polymorphism of glycerides Chem. Rev. 62 1962 433 456
25. K. Sato Crystallization behaviour of fats and lipids - a review Chem. Eng. Sci. 56 2001 2255 2265 (Pubitemid 33763447)
26. C. Himawan, V.M. Starov, and A.G.F. Stapley Thermodynamic and kinetic aspects of fat crystallization Adv. Colloid Interface Sci. 122 2006 3 33 (Pubitemid 44404027)
27. N. Khan, and D.Q.M. Craig Role of blooming in determining the storage stability of lipid-based dosage forms J. Pharm. Sci. 93 2004 2962 2971 (Pubitemid 39657800)
28. Y.W. Choy, N. Khan, and K.H. Yuen Significance of lipid matrix aging on in vitro release and in vivo bioavailability Int. J. Pharm. 299 2005 55 64 (Pubitemid 40962406)
29. C. Guse, S. Koennings, T. Blunk, J. Siepmann, and A. Goepferich Programmable implants - from pulsatile to controlled release Int. J. Pharm. 314 2006 161 169
30. J. Siepmann, and F. Siepmann Mathematical modeling of drug delivery Int. J. Pharm. 364 2008 328 343
31. S. Koennings, A. Berie, J. Tessmar, T. Blunk, and A. Goepferich Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices J. Control. Release 119 2007 173 181 (Pubitemid 46754503)
32. M. Windbergs, C.J. Strachan, and P. Kleinebudde Influence of structural variations on drug release from lipid/polyethylene glycol matrices Eur. J. Pharm. Sci. 37 2009 555 562
33. J.W. Hagemann Thermal behavior and polymorphism of acylglycerides N. Garti, K. Sato, Crystallization and Polymorphism of Fats and Fatty Acids 1988 Marcel Dekker New York 9 97
34. J. Vergnaud Controlled Drug Release of Oral Dosage Forms 1993 Ellis Horwood Limited Chichester